PG vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Procter & Gamble Company and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
The Procter & Gamble Company · Consumer Defensive
$150.38
+10.0% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
PG has more upside to fair value
(+10.0%).
PG trades at a lower forward P/E
(21.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PG |
TMO |
| Current Price |
$150.38 |
$464.61 |
| Fair Value Estimate |
$165.39 |
$498.27 |
| Upside to Fair Value |
+10.0%
|
+7.2%
|
| Market Cap |
$350.2B |
$172.7B |
| Forward P/E |
21.5x
|
25.2x
|
| EV / EBITDA |
15.1x
|
19.1x
|
| Price / Sales |
4.0x
|
3.8x
|
| Price / FCF |
23.3x
|
25.6x
|
| Revenue Growth YoY |
+7.4%
|
+6.2%
|
| Gross Margin |
50.3%
|
39.4%
|
| Operating Margin |
23.2%
|
17.8%
|
| Return on Equity |
31.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.29%
|
3.91%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
The Procter & Gamble Company is a leading global consumer defensive company specializing in household and personal products with a strong portfolio across fabric care, baby and family care, beauty, health care, and grooming. The business quality is high, supported by a durable competitive moat from strong brands, consistent earnings growth, and prudent capital allocation emphasizing dividends and…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
PG |
TMO |
| Zone Low |
$124.04 |
$373.70 |
| Zone High |
$140.58 |
$423.53 |
| In Buy Zone? |
No
|
No
|